Lovelace Biomedical has an over 70-year history in the area of respiratory drug delivery. Throughout this history, the question of how to build relationships between non-clinical and clinical doses has always come up. Philip Kuehl is a co-author of a recent article published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery that details this process in a direct manner. If you wish to learn more about inhalation dosimetry between species reach out to an expert at Lovelace Biomedical.
View the full article here: https://www.liebertpub.com/doi/10.1089/jamp.2023.0041